The new COVID-19 UK IBD Tool for patients is now live. The tool aims to help you and your team to identify and reach your moderate and high-risk IBD patients. This is to support and complement the work you and […]
Introduction Inflammatory Bowel Disease (IBD), comprising Crohn’s Disease (CD) and Ulcerative Colitis (UC), is a condition in which the gastrointestinal immune system responds inappropriately. It is therefore often treated with immune suppression medications to control inflammation and to prevent ‘flares’, […]
Important update from the BSG VP Hepatology and the BASL and BSG Presidents Recent government announcements have indicated that the liver patients to be included in the ‘shielding group’ should be those receiving immunosuppression for a liver transplant or for […]
This evening, the Prime Minister has issued specific COVID-19 guidance for the 1.5million most vulnerable people living with chronic illness in the UK. This advises ‘shielding’ measures to reduce the transmission of COVID-19 infection and the risks from COVID-19 disease. […]
The BSG is monitoring the spread of the new Coronavirus (COVID-19) very carefully. We are aware that the new virus has caused understandable concern for many patients living with Gastrointestinal or Liver diseases, particularly those conditions that require immunosuppressive drugs. […]